ArticleJournal of Cancer2018

Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKI.

Liping Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.